These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 27000313)
21. Magnolol effectively ameliorates diabetic peripheral neuropathy in mice. Yang J; Wei Y; Zhao T; Li X; Zhao X; Ouyang X; Zhou L; Zhan X; Qian M; Wang J; Shen X Phytomedicine; 2022 Dec; 107():154434. PubMed ID: 36122436 [TBL] [Abstract][Full Text] [Related]
22. Transcriptome-wide Association Study Identifies Genetically Dysregulated Genes in Diabetic Neuropathy. Lan D; Jiang HY; Su X; Zhao Y; Du S; Li Y; Bi R; Zhang DF; Yang Q Comb Chem High Throughput Screen; 2021; 24(2):319-325. PubMed ID: 32772906 [TBL] [Abstract][Full Text] [Related]
23. Gene and protein expression profiles of JAK-STAT signalling pathway in the developing brain of the Ts1Cje down syndrome mouse model. Lee HC; Md Yusof HH; Leong MP; Zainal Abidin S; Seth EA; Hewitt CA; Vidyadaran S; Nordin N; Scott HS; Cheah PS; Ling KH Int J Neurosci; 2019 Sep; 129(9):871-881. PubMed ID: 30775947 [No Abstract] [Full Text] [Related]
24. JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy. Tao J; Mariani L; Eddy S; Maecker H; Kambham N; Mehta K; Hartman J; Wang W; Kretzler M; Lafayette RA Clin J Am Soc Nephrol; 2020 Jul; 15(7):973-982. PubMed ID: 32354727 [TBL] [Abstract][Full Text] [Related]
25. Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models. Harlan SM; Heinz-Taheny KM; Sullivan JM; Wei T; Baker HE; Jaqua DL; Qi Z; Cramer MS; Shiyanova TL; Breyer MD; Heuer JG J Am Soc Nephrol; 2018 Feb; 29(2):477-491. PubMed ID: 29061652 [TBL] [Abstract][Full Text] [Related]
26. Advantages of omics approaches for elucidating metabolic changes in diabetic peripheral neuropathy. Yako H; Niimi N; Takaku S; Sango K Front Endocrinol (Lausanne); 2023; 14():1208441. PubMed ID: 38089620 [TBL] [Abstract][Full Text] [Related]
27. Association of vitamin D deficiency with diabetic peripheral neuropathy and diabetic nephropathy in Tianjin, China. Fan L; Zhang Y; Zhu J; Song Y; Lin J Asia Pac J Clin Nutr; 2018; 27(3):599-606. PubMed ID: 29737807 [TBL] [Abstract][Full Text] [Related]
28. SP6616 as a Kv2.1 inhibitor efficiently ameliorates peripheral neuropathy in diabetic mice. Zhu X; Chen Y; Xu X; Xu X; Lu Y; Huang X; Zhou J; Hu L; Wang J; Shen X EBioMedicine; 2020 Nov; 61():103061. PubMed ID: 33096484 [TBL] [Abstract][Full Text] [Related]
30. Genomic expression profiling and bioinformatics analysis on diabetic nephrology with ginsenoside Rg3. Wang J; Cui C; Fu L; Xiao Z; Xie N; Liu Y; Yu L; Wang H; Luo B Mol Med Rep; 2016 Aug; 14(2):1162-72. PubMed ID: 27279428 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes. Hinder LM; Sas KM; O'Brien PD; Backus C; Kayampilly P; Hayes JM; Lin CM; Zhang H; Shanmugam S; Rumora AE; Abcouwer SF; Brosius FC; Pennathur S; Feldman EL Sci Rep; 2019 Jan; 9(1):881. PubMed ID: 30696927 [TBL] [Abstract][Full Text] [Related]
32. Animal Models of Type 2 Diabetes Complications: A Review. Sun Z; Liu Y; Zhao Y; Xu Y Endocr Res; 2024 Jan; 49(1):46-58. PubMed ID: 37950485 [TBL] [Abstract][Full Text] [Related]
33. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy. Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721 [TBL] [Abstract][Full Text] [Related]
34. Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus. Guo K; Elzinga S; Eid S; Figueroa-Romero C; Hinder LM; Pacut C; Feldman EL; Hur J Epigenetics; 2019 Aug; 14(8):766-779. PubMed ID: 31132961 [TBL] [Abstract][Full Text] [Related]
35. Genomic DNA Methylation in Diabetic Chronic Complications in Patients With Type 2 Diabetes Mellitus. Wang X; Yang W; Zhu Y; Zhang S; Jiang M; Hu J; Zhang HH Front Endocrinol (Lausanne); 2022; 13():896511. PubMed ID: 35846305 [TBL] [Abstract][Full Text] [Related]
36. JAK inhibition in the treatment of diabetic kidney disease. Brosius FC; Tuttle KR; Kretzler M Diabetologia; 2016 Aug; 59(8):1624-7. PubMed ID: 27333885 [TBL] [Abstract][Full Text] [Related]
37. Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy. Preguiça I; Alves A; Nunes S; Gomes P; Fernandes R; Viana SD; Reis F Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963709 [TBL] [Abstract][Full Text] [Related]
38. IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy. Gu T; Horová E; Möllsten A; Seman NA; Falhammar H; Prázný M; Brismar K; Gu HF J Diabetes Complications; 2012; 26(5):393-8. PubMed ID: 22770937 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm. Gholaminejad A; Fathalipour M; Roointan A BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202 [TBL] [Abstract][Full Text] [Related]
40. Gender-specific differences in diabetic neuropathy in BTBR ob/ob mice. O'Brien PD; Hur J; Robell NJ; Hayes JM; Sakowski SA; Feldman EL J Diabetes Complications; 2016; 30(1):30-7. PubMed ID: 26525588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]